Integrated RNA and DNA sequencing improves mutation detection in low purity tumors
View/ Open
Author
Wilkerson, Matthew D.
Cabanski, Christopher R.
Sun, Wei
Hoadley, Katherine A.
Walter, Vonn
Mose, Lisle E.
Troester, Melissa A.
Parker, Joel S.
Perou, Charles M.
Hayes, D. Neil
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1093/nar/gku489Metadata
Show full item recordCitation
Wilkerson, M. D., C. R. Cabanski, W. Sun, K. A. Hoadley, V. Walter, L. E. Mose, M. A. Troester, et al. 2014. “Integrated RNA and DNA sequencing improves mutation detection in low purity tumors.” Nucleic Acids Research 42 (13): e107. doi:10.1093/nar/gku489. http://dx.doi.org/10.1093/nar/gku489.Abstract
Identifying somatic mutations is critical for cancer genome characterization and for prioritizing patient treatment. DNA whole exome sequencing (DNA-WES) is currently the most popular technology; however, this yields low sensitivity in low purity tumors. RNA sequencing (RNA-seq) covers the expressed exome with depth proportional to expression. We hypothesized that integrating DNA-WES and RNA-seq would enable superior mutation detection versus DNA-WES alone. We developed a first-of-its-kind method, called UNCeqR, that detects somatic mutations by integrating patient-matched RNA-seq and DNA-WES. In simulation, the integrated DNA and RNA model outperformed the DNA-WES only model. Validation by patient-matched whole genome sequencing demonstrated superior performance of the integrated model over DNA-WES only models, including a published method and published mutation profiles. Genome-wide mutational analysis of breast and lung cancer cohorts (n = 871) revealed remarkable tumor genomics properties. Low purity tumors experienced the largest gains in mutation detection by integrating RNA-seq and DNA-WES. RNA provided greater mutation signal than DNA in expressed mutations. Compared to earlier studies on this cohort, UNCeqR increased mutation rates of driver and therapeutically targeted genes (e.g. PIK3CA, ERBB2 and FGFR2). In summary, integrating RNA-seq with DNA-WES increases mutation detection performance, especially for low purity tumors.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117748/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:12785959
Collections
- HMS Scholarly Articles [17918]
Contact administrator regarding this item (to report mistakes or request changes)